Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Hogarth

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Social Science & Medicine (1982)|December 22, 2009
Negotiating the boundary between medicine and consumer culture: online marketing of nutrigenetic testsPaula M Saukko, Matthew Reed, Nicky Britten, et al.
Plos One|July 18, 2025
Prognosis, treatment decision-making and value: A qualitative exploration of the emerging role of breast cancer prognostic assaysGillian Parker, Stuart Hogarth, Jennifer Fishman, et al.
BMJ (Clinical Research Ed.)|February 21, 2019
Dangerous diagnostics? Regulatory reform in the genomic eraKelly Holloway, Fiona A Miller, Alberto Gutierrez, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 2, 2019
Health Canada needs to act on laboratory-developed diagnosticsKelly Holloway, Fiona A Miller, François Rousseau, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 11, 2020
Responses to "Health Canada needs to act on laboratory-developed diagnostics"Kelly Holloway, Fiona A Miller, François Rousseau, et al.
Food and Drug Law Journal|June 19, 2008
Closing the gaps--enhancing the regulation of genetic tests using responsive regulationStuart Hogarth, Kathy Liddell, Tom Ling, et al.
Nature Biotechnology|December 11, 2025
Mapping the patent landscape of cancer diagnosticsMateo Aboy, Kathleen Liddell, Cristina Crespo, et al.
BMJ (Clinical Research Ed.)|March 15, 2008
Genetic tests for common diseases: new insights, old concernsDavid Melzer, Stuart Hogarth, Katherine Liddell, et al.
Nature Reviews. Genetics|June 2, 2011
The future of direct-to-consumer clinical genetic testsFelix W Frueh, Henry T Greely, Robert C Green, et al.
Lancet (London, England)|January 22, 2024
GRAIL-Galleri: why the special treatment?Clare Turnbull, Nicholas Wald, Richard Sullivan, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Social Science & Medicine (1982)|December 22, 2009
Negotiating the boundary between medicine and consumer culture: online marketing of nutrigenetic testsPaula M Saukko, Matthew Reed, Nicky Britten, et al.
Plos One|July 18, 2025
Prognosis, treatment decision-making and value: A qualitative exploration of the emerging role of breast cancer prognostic assaysGillian Parker, Stuart Hogarth, Jennifer Fishman, et al.
BMJ (Clinical Research Ed.)|February 21, 2019
Dangerous diagnostics? Regulatory reform in the genomic eraKelly Holloway, Fiona A Miller, Alberto Gutierrez, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 2, 2019
Health Canada needs to act on laboratory-developed diagnosticsKelly Holloway, Fiona A Miller, François Rousseau, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 11, 2020
Responses to "Health Canada needs to act on laboratory-developed diagnostics"Kelly Holloway, Fiona A Miller, François Rousseau, et al.
Food and Drug Law Journal|June 19, 2008
Closing the gaps--enhancing the regulation of genetic tests using responsive regulationStuart Hogarth, Kathy Liddell, Tom Ling, et al.
Nature Biotechnology|December 11, 2025
Mapping the patent landscape of cancer diagnosticsMateo Aboy, Kathleen Liddell, Cristina Crespo, et al.
BMJ (Clinical Research Ed.)|March 15, 2008
Genetic tests for common diseases: new insights, old concernsDavid Melzer, Stuart Hogarth, Katherine Liddell, et al.
Nature Reviews. Genetics|June 2, 2011
The future of direct-to-consumer clinical genetic testsFelix W Frueh, Henry T Greely, Robert C Green, et al.
Lancet (London, England)|January 22, 2024
GRAIL-Galleri: why the special treatment?Clare Turnbull, Nicholas Wald, Richard Sullivan, et al.
Pageof 3